EP0000452B1 - Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique. - Google Patents
Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique. Download PDFInfo
- Publication number
- EP0000452B1 EP0000452B1 EP78400026A EP78400026A EP0000452B1 EP 0000452 B1 EP0000452 B1 EP 0000452B1 EP 78400026 A EP78400026 A EP 78400026A EP 78400026 A EP78400026 A EP 78400026A EP 0000452 B1 EP0000452 B1 EP 0000452B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- formula
- radical
- compound
- compounds
- reacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- JAPMJSVZDUYFKL-UHFFFAOYSA-N C1C2C1CCC2 Chemical compound C1C2C1CCC2 JAPMJSVZDUYFKL-UHFFFAOYSA-N 0.000 description 1
- RXYPXQSKLGGKOL-UHFFFAOYSA-N CN1CCN(C)CC1 Chemical compound CN1CCN(C)CC1 RXYPXQSKLGGKOL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Definitions
- the present invention relates to oxadiazole derivatives, their preparation and their therapeutic use.
- Certain compounds of the invention form pharmaceutically acceptable acid addition salts; these salts are part of the invention.
- R 1 and R 2 each represent, independently of one another, a chlorine atom, a fluorine atom or the methyl radical.
- the compounds are prepared by reacting a compound of formula (II) with ammonia or an amine HNR 3 R 4 (III), then the intermediate obtained with hydroxylamine.
- the reaction is carried out in a solvent such as a lower alcohol, acetone, benzene, an ether, chloroform, but preferably in methanol.
- a solvent such as a lower alcohol, acetone, benzene, an ether, chloroform, but preferably in methanol.
- the first part of the reaction is carried out in an alkalized mixture of water and acetone, at a temperature ranging from 0 to 10 ° C.
- the second part of the reaction is carried out in a polar solvent, such as an alcohol, in the presence of a tertiary base, without isolation of the intermediate.
- a polar solvent such as an alcohol
- the reaction with the compound (IV) is carried out in a solvent such as an ether, chloroform, a hydrocarbon such as benzene, a lower alcohol, but preferably in chloroform.
- a solvent such as an ether, chloroform, a hydrocarbon such as benzene, a lower alcohol, but preferably in chloroform.
- the compounds (II) are new and form part of the invention.
- the product is chromatographed on a silica column.
- Example 2 [N, N-bis (2-hydroxyethyl) -formamidino] -3 (2,6-dichloro benzyl) -5 oxadiazole-1, 2, 4 and its hydrochloride.
- the solid obtained is crystallized from a 70/30 isopropyl ether / isopropanol mixture.
- the monohydrochloride melts at 257 ° C.
- the crude intermediate is dissolved in 60 ml of ethanol and the solution obtained is added to a suspension of 10.75 g (0.15 mole) of hydroxylamine hydrochloride in 25 ml of pyridine.
- the reaction is slow and very slightly exothermic.
- the reaction is allowed to take place overnight.
- the temperature generally stabilizes around 40 °.
- the precipitated product is filtered off, then washed with ethanol and ether.
- the filtrate is concentrated to dryness, then taken up in water and made alkaline with 2N sodium hydroxide.
- a second jet of oxadiazole precipitates; it is drained and washed with ethanol and ether.
- the 3-amino (2,6-dichloro-benzyl) -5 oxadiazole-1, 2, 4 is recrystallized from ethanol, which melts at 185 ° C.
- the compounds of the invention have been subjected to pharmacological tests which have shown their activity as antihypertensive agents.
- the toxicity of the compounds (I) was determined i.p., in the male CDI rat (Charles River) of 100 to 120 g, kept fasting for 18 hours.
- the lethal dose 50% (LD 50) is shown in Table II.
- Antihypertensive activity is evaluated in spontaneously hypertensive male rats according to the method of Gerold and Tschirky (Arzneim. Forsch. 1968, 18, 1285). Systolic pressure is measured by sensing the pulse at the caudal artery.
- the invention therefore includes all pharmaceutical compositions containing at least one of the compounds (I) as active ingredient, in combination with any excipients suitable for their administration, mainly by the oral route, but also by the endorectal or parenteral route.
- the daily oral dosage can vary from 4 to 100 mg.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7721447A FR2397408A1 (fr) | 1977-07-12 | 1977-07-12 | Derives d'oxadiazole, leur preparation et leur application en therapeutique |
FR7721447 | 1977-07-12 | ||
FR7817114 | 1978-06-08 | ||
FR7817114A FR2428034A2 (fr) | 1978-06-08 | 1978-06-08 | Derives d'oxadiazole-1,2,4, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0000452A1 EP0000452A1 (fr) | 1979-01-24 |
EP0000452B1 true EP0000452B1 (fr) | 1981-05-06 |
Family
ID=26220123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP78400026A Expired EP0000452B1 (fr) | 1977-07-12 | 1978-06-20 | Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique. |
Country Status (17)
Country | Link |
---|---|
US (2) | US4261994A (xx) |
EP (1) | EP0000452B1 (xx) |
JP (1) | JPS5834473B2 (xx) |
AR (1) | AR222310A1 (xx) |
AT (1) | AT362367B (xx) |
AU (1) | AU515506B2 (xx) |
CA (1) | CA1130806A (xx) |
DE (1) | DE2860691D1 (xx) |
DK (1) | DK307378A (xx) |
ES (2) | ES471609A1 (xx) |
FI (1) | FI782220A (xx) |
GR (1) | GR64924B (xx) |
IL (1) | IL55104A (xx) |
IT (1) | IT1096906B (xx) |
NO (1) | NO782404L (xx) |
NZ (1) | NZ187825A (xx) |
PT (1) | PT68267A (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5625877B2 (xx) * | 1973-06-19 | 1981-06-15 | ||
EP0000452B1 (fr) * | 1977-07-12 | 1981-05-06 | Synthelabo | Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique. |
US4914112A (en) * | 1986-06-03 | 1990-04-03 | Sumitomo Pharmaceuticals Company, Limited | Aminoazole derivatives and their production and use |
US5180731A (en) * | 1986-06-03 | 1993-01-19 | Sumitomo Pharmaceuticals Company, Limited | Aminoazole derivatives and their production and use |
AT395853B (de) * | 1991-01-31 | 1993-03-25 | Chem Pharm Forsch Gmbh | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung |
WO1993009106A1 (en) * | 1991-10-28 | 1993-05-13 | Tsentr Po Khimii Lekarstvennykh Sredstv | Derivatives of 5-phenoxymethyl-1,2,4-oxadiazol, their salts, method of obtaining them and a pharmaceutical preparation with antihypertensive, antianginal, antiarrhythmic and antiglaucomatomic properties based on them |
CN1131209C (zh) * | 1995-05-09 | 2003-12-17 | 拜尔公司 | 可用作杀虫剂和除草剂的烷基-二卤代苯基取代的酮烯醇 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL132134C (xx) * | 1963-03-22 | |||
US3564607A (en) * | 1965-07-30 | 1971-02-16 | Olin Corp | Halogenated aryloxyacetyl cyanamides |
DE1670338A1 (de) * | 1966-03-14 | 1972-08-10 | Heyden Chem Fab | Verfahren zur Herstellung von antimikrobiell wirksamen Nitrofuranderivaten |
FR1559629A (xx) * | 1966-09-23 | 1969-03-14 | ||
US3452035A (en) * | 1966-12-23 | 1969-06-24 | American Cyanamid Co | 2 - amino - 5 - (5 - nitro - 1 - substituted-2 - imidazolyl) - 1,3,4 - thiadiazoles and oxadiazoles |
US3720685A (en) * | 1970-07-15 | 1973-03-13 | Squibb & Sons Inc | 3-amino-5-benzyl-1,2,4-oxadiazoles |
GB1314427A (en) * | 1970-07-17 | 1973-04-26 | Beecham Group Ltd | Amino acid esters of 2,2-dialkyl-4-4-pyridyl-2h-7-substituted- chromen-5-ols |
DE2054342A1 (de) * | 1970-11-05 | 1972-05-10 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Neue 1,2,4-Oxdiazole |
US3879407A (en) * | 1973-02-09 | 1975-04-22 | Johnson & Son Inc S C | 1,2,4-Oxadiazole and thiadiazole esters and compositions containing same |
HU169666B (xx) * | 1973-12-29 | 1977-02-28 | ||
EP0000452B1 (fr) * | 1977-07-12 | 1981-05-06 | Synthelabo | Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique. |
-
1978
- 1978-06-20 EP EP78400026A patent/EP0000452B1/fr not_active Expired
- 1978-06-20 DE DE7878400026T patent/DE2860691D1/de not_active Expired
- 1978-07-07 US US05/922,527 patent/US4261994A/en not_active Expired - Lifetime
- 1978-07-07 DK DK783073A patent/DK307378A/da not_active Application Discontinuation
- 1978-07-07 IL IL55104A patent/IL55104A/xx unknown
- 1978-07-10 PT PT68267A patent/PT68267A/pt unknown
- 1978-07-10 NZ NZ187825A patent/NZ187825A/xx unknown
- 1978-07-10 AU AU37909/78A patent/AU515506B2/en not_active Expired
- 1978-07-10 NO NO782404A patent/NO782404L/no unknown
- 1978-07-10 CA CA307,090A patent/CA1130806A/en not_active Expired
- 1978-07-10 GR GR56739A patent/GR64924B/el unknown
- 1978-07-10 IT IT25497/78A patent/IT1096906B/it active
- 1978-07-11 FI FI782220A patent/FI782220A/fi not_active Application Discontinuation
- 1978-07-11 JP JP53085017A patent/JPS5834473B2/ja not_active Expired
- 1978-07-11 ES ES471609A patent/ES471609A1/es not_active Expired
- 1978-07-12 AT AT505378A patent/AT362367B/de not_active IP Right Cessation
- 1978-07-12 AR AR272930A patent/AR222310A1/es active
-
1979
- 1979-03-12 ES ES478527A patent/ES478527A1/es not_active Expired
- 1979-04-27 US US06/034,197 patent/US4242352A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU3790978A (en) | 1980-01-17 |
AR222310A1 (es) | 1981-05-15 |
AT362367B (de) | 1981-05-11 |
NO782404L (no) | 1979-01-15 |
FI782220A (fi) | 1979-01-13 |
NZ187825A (en) | 1980-03-05 |
DE2860691D1 (en) | 1981-08-13 |
IL55104A (en) | 1982-07-30 |
IT1096906B (it) | 1985-08-26 |
JPS5834473B2 (ja) | 1983-07-27 |
ES471609A1 (es) | 1979-09-16 |
CA1130806A (en) | 1982-08-31 |
AU515506B2 (en) | 1981-04-09 |
ATA505378A (de) | 1980-10-15 |
US4261994A (en) | 1981-04-14 |
DK307378A (da) | 1979-01-13 |
IL55104A0 (en) | 1978-09-29 |
GR64924B (en) | 1980-06-09 |
ES478527A1 (es) | 1979-05-16 |
IT7825497A0 (it) | 1978-07-10 |
JPS5419978A (en) | 1979-02-15 |
PT68267A (fr) | 1978-08-01 |
US4242352A (en) | 1980-12-30 |
EP0000452A1 (fr) | 1979-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU80880A1 (fr) | Derives d'alkylenediamines | |
EP0003383A2 (fr) | Dérivés de 4-amino-3-sulfonamido-pyridine | |
EP0092458A2 (fr) | Dérives d'imidazo(1,2-a)pyridine, leur préparation et leur application en thérapeutique | |
EP0000452B1 (fr) | Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique. | |
HU191316B (en) | Process for producing (2-oxo-1,2,3,5-tetrahydro-imidazo /2,1-b/ quinazoline)-oxy-lakyl-amides and pharmacutical compositions containing them | |
EP0117771B1 (fr) | Imino-2 pyrrolidines, leur procédé de préparation et leurs applications en thérapeutique | |
EP0076199B1 (fr) | Nouvelles triazoloquinazolones et leurs sels, procédé et intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant | |
EP0021940A1 (fr) | Nouveaux dérivés aminés du benzothiazole, leur procédé de préparation et leur application en thérapeutique | |
EP0086126B1 (fr) | Dérivés d'imidazolidine, leur préparation et leur application en thérapeutique | |
FR2612517A1 (fr) | Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant | |
CA1338637C (fr) | Derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant | |
CH644124A5 (fr) | Oxoimidazoquinoxalines et leurs sels, leurs procedes de preparation et les medicaments les renfermant. | |
EP0079810A1 (fr) | Nouveaux dérivés de la phényl-4 quinazoline actifs sur le système nerveux central | |
BE779775A (fr) | Derives de l'uree, procede pour les preparer et leurs applications | |
EP0183577B1 (fr) | Dérivés du thiadiazole actifs sur le système nerveux central, procédé d'obtension et compositions pharmaceutiques les contenant | |
EP0015171A1 (fr) | Dérivés condensés de pyrrolidine ou de pipéridine, leur procédé de préparation et composition les contenant | |
FR2547822A1 (fr) | Acylpiperazinoquinazolines substituees utiles comme medicaments et procede pour leur preparation | |
FR2516510A1 (fr) | Derives de la (trimethoxy-3,4,5-cinnamoyl)-1-aminocarbonylethyl-4-piperazine substituee utilisables en pharmacie et procede pour leur preparation | |
EP0106860B1 (fr) | Nouvelles carboxamidoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant | |
EP0157762B1 (fr) | Nouvelles piperidinoguanidines substituees, leur procede de preparation et les compositions pharmaceutiques en renfermant | |
EP0105881A1 (fr) | Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant. | |
WO1991008201A1 (fr) | Derives d'(hetero) arylmethyloxy-4 phenyl diazole, leur procede de preparation et leur application en therapeutique | |
EP0012051A1 (fr) | Dérivés d'amino-3 dioxo-2,4 (1H,3H) quinazolines, leur procédé de préparation et composition thérapeutique les contenant | |
EP0445116A1 (fr) | [(aryl-4-piperazinyl-1)-2 ethoxy]-3 p-cymene, les derives ortho, meta, para monosubstitues ou disubstitues sur le noyau phenyle dudit produit, le procede de preparation desdits derives, et les medicaments contenant lesdits composes comme principe actif | |
EP0076713A1 (fr) | Nouveaux dérivés de l'aminométhyl 1H-indole 4-méthanol et leurs sels, leur procédé et les intermédiaires de préparation, leur application à titre de médicaments, les compositions les renfermant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
17P | Request for examination filed | ||
DET | De: translation of patent claims | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19810630 |
|
REF | Corresponds to: |
Ref document number: 2860691 Country of ref document: DE Date of ref document: 19810813 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: SYNTHELABO |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19820617 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19820630 Year of fee payment: 5 Ref country code: NL Payment date: 19820630 Year of fee payment: 5 Ref country code: DE Payment date: 19820630 Year of fee payment: 5 Ref country code: CH Payment date: 19820630 Year of fee payment: 5 Ref country code: BE Payment date: 19820630 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19830609 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Effective date: 19830620 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19830621 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Effective date: 19830630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19840101 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19840301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19850228 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19881117 |
|
EUG | Se: european patent has lapsed |
Ref document number: 78400026.7 Effective date: 19850610 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |